share_log

iBio Inc | 4: Statement of changes in beneficial ownership of securities-Officer Duran Felipe

iBio Inc | 4: Statement of changes in beneficial ownership of securities-Officer Duran Felipe

iBio Inc | 4:持股变动声明-高管 Duran Felipe
美股SEC公告 ·  04/26 17:08

Moomoo AI 已提取核心信息

Felipe Duran, the Chief Financial Officer of iBio Inc (IBIO.US), was involved in a transaction with the company's stock on April 25, 2024. The specific details of the transaction, including the action type, status, number of shares, nature of shares, transaction price, and post-transaction holdings, were not disclosed in the announcement. As a key insider of the company, any trading activity by Duran is closely watched by investors for indications of the company's financial health and insider confidence.
Felipe Duran, the Chief Financial Officer of iBio Inc (IBIO.US), was involved in a transaction with the company's stock on April 25, 2024. The specific details of the transaction, including the action type, status, number of shares, nature of shares, transaction price, and post-transaction holdings, were not disclosed in the announcement. As a key insider of the company, any trading activity by Duran is closely watched by investors for indications of the company's financial health and insider confidence.
iBio Inc(IBIO.US)首席财务官费利佩·杜兰于2024年4月25日参与了该公司股票的交易。该交易的具体细节,包括行动类型、状态、股票数量、股票性质、交易价格和交易后持有量,未在公告中披露。作为公司的主要内部人士,杜兰的任何交易活动都受到投资者的密切关注,以寻找公司财务状况和内部信心的迹象。
iBio Inc(IBIO.US)首席财务官费利佩·杜兰于2024年4月25日参与了该公司股票的交易。该交易的具体细节,包括行动类型、状态、股票数量、股票性质、交易价格和交易后持有量,未在公告中披露。作为公司的主要内部人士,杜兰的任何交易活动都受到投资者的密切关注,以寻找公司财务状况和内部信心的迹象。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息